CTK Biotech Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • CTK Biotech's estimated annual revenue is currently $19.8M per year.(i)
  • CTK Biotech's estimated revenue per employee is $251,000

Employee Data

  • CTK Biotech has 79 Employees.(i)
  • CTK Biotech grew their employee count by -5% last year.

CTK Biotech's People

NameTitleEmail/Phone
1
Sr VP, Rapid Screening & Precision TestingReveal Email/Phone
2
Reagent Product ManagerReveal Email/Phone
3
RA ManagerReveal Email/Phone
4
Product ManagerReveal Email/Phone
5
Associate Project ManagerReveal Email/Phone
6
Assistant Production ManagerReveal Email/Phone
7
Asst.Product ManagerReveal Email/Phone
8
Country Marketing ManagerReveal Email/Phone
9
Associate ScientistReveal Email/Phone
10
Business Development ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is CTK Biotech?

Located in San Diego, California, an area well known for biotechnology and scientific discovery, CTK Biotech develops and manufactures innovative immunodiagnostic tools and point of care diagnostic test kits for the IVD community worldwide. Our IVD products allow medical professionals to quickly and accurately diagnose disease and meet patient needs. The simplicity and portability of our test kits make them ideally suited for use in a wide range of settings including remote locations and countries with large populations where complicated medical diagnostic systems are not readily available. CTK Biotech is focused on quality and strives to stay ahead of changing market conditions. With top notch experts at the helm, we identify and adopt new technologies, plan for upcoming trends and achieve commercialization as a result of our advances. CTK invests heavily in research to develop new products in response to market demands and continuously improve our point of care tests. For each step of product development we have established a proficient pathway to convert scientific discoveries and the latest technologies into diagnostic solutions for use in the real world. We have a unique business model in that we produce our own recombinant antigens and antibodies for later use in the production of our test kits. Our skill in raw material identification, generation and purification gives us an edge over our competitors as we can guarantee excellent control over quality, supply and consistency between lots to ensure that our customers receive the highest quality products at exceptional pricing. Customer service is an equally important factor to our business. We strive to obtain and retain our loyal customers by exceeding their expectations with unparalleled service and creating sustainable value. From navigating the regulatory environment to regular communication from the time of order to delivery, CTK is known for excellence in quality and service.

keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals

N/A

Total Funding

79

Number of Employees

$19.8M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

CTK Biotech News

2022-04-17 - Rapid Test Kit Market Trend, Forecast, Drivers, Restraints, Company Profiles and Key Players Analysis by 2030

... Ray Biotech Life, Inc., OraSure Technologies, BioMedomics Inc., CTK Biotech, Inc., AlphaBiolabs Ltd., GeneMatrix Inc., Seegene Inc.,...

2022-04-17 - Global Nasal Aspirate Testing Market by Products,Industry ...

... F. Hoffmann-La Roche, QIAGEN, BioMaxima SA, CTK Biotech, VivaChek Biotech (Hangzhou), Sensing Self,PTE, Hangzhou Biotest Biotech.

2022-03-22 - Malaria positivity following a single oral dose of azithromycin ...

An OnSite Pf/Pan antigen rapid test (CTK Biotech Inc, USA) was used to detect Plasmodium falciparum among all participants regardless of...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$26.1M794%N/A
#2
$23.5M8113%N/A
#3
$25.3M8249%N/A
#4
$17.4M839%N/A
#5
$24.1M834%N/A